Systemic Inflammatory Response Syndrome
"Systemic Inflammatory Response Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever >38 degrees C or HYPOTHERMIA <36 degrees C; (2) TACHYCARDIA >90 beat/minute; (3) tachypnea >24 breaths/minute; (4) LEUKOCYTOSIS >12,000 cells/cubic mm or 10% immature forms. While usually related to infection, SIRS can also be associated with noninfectious insults such as TRAUMA; BURNS; or PANCREATITIS. If infection is involved, a patient with SIRS is said to have SEPSIS.
Descriptor ID |
D018746
|
MeSH Number(s) |
C23.550.470.790 C23.550.835.900
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Systemic Inflammatory Response Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Systemic Inflammatory Response Syndrome".
- Systemic Inflammatory Response Syndrome
- Sepsis
This graph shows the total number of publications written about "Systemic Inflammatory Response Syndrome" by people in this website by year, and whether "Systemic Inflammatory Response Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2005 | 3 | 0 | 3 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2013 | 0 | 2 | 2 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2017 | 2 | 2 | 4 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
2022 | 2 | 5 | 7 |
2023 | 0 | 1 | 1 |
2024 | 1 | 2 | 3 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Systemic Inflammatory Response Syndrome" by people in Profiles.
-
Goel AR, Yalcindag A. An Update on Multi-System Inflammatory Syndrome in Children. Curr Rheumatol Rep. 2025 Jan 30; 27(1):16.
-
Msellati A, Loo C, Toerien L, Catanzano T. Pediatric Presentations of COVID-19 and Pertinent Radiologic Findings. Semin Ultrasound CT MR. 2024 Aug; 45(4):339-343.
-
Ghodasara SK, Hauser KM, Oldewurtel KM, Rolandelli RH, Nemeth ZH. A Comparison of Clinical Outcomes of Colectomies for Pediatric and Adult Patients With Inflammatory Bowel Disease. Am Surg. 2024 Nov; 90(11):2921-2929.
-
Weinstein R, Naber CE, Brumme K. Revisiting dexamethasone use in the pediatric emergency department. Curr Opin Pediatr. 2024 06 01; 36(3):251-255.
-
Colosimo C, Ingram B, Weaver J, Offner P, Yon J. Increased Complications of Emergent Surgical Procedures During the First Wave of COVID-19. J Surg Res. 2023 06; 286:16-22.
-
Harthan AA, Nadiger M, McGarvey JS, Hanson K, Gharpure VP, Bjornstad EC, Chiotos K, Miller AS, Reikoff RA, Gajic O, Kumar V, Walkey AJ, Kashyap R, Tripathi S. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals. Pharmacotherapy. 2022 07; 42(7):529-539.
-
Goel AR, Chiang SS, Ibrahim O, Yalcindag A. Multisystem Inflammatory Syndrome in an Adolescent Following SARS-CoV-2 Exposure Despite Three Doses of a COVID-19 Vaccine. R I Med J (2013). 2022 Jun 01; 105(5):41-45.
-
Sayed IA, Bhalala U, Strom L, Tripathi S, Kim JS, Michaud K, Chiotos K, Dapul HR, Gharpure VP, Bjornstad EC, Heneghan JA, Irby K, Montgomery V, Gupta N, Gupta M, Boman K, Bansal V, Kashyap R, Walkey AJ, Kumar VK, Gist KM. Gastrointestinal Manifestations in Hospitalized Children With Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry. Pediatr Infect Dis J. 2022 09 01; 41(9):751-758.
-
Wangu Z, Swartz H, Doherty M. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. BMJ Case Rep. 2022 Mar 30; 15(3).
-
Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone C, Dauphin A, Boribong BP, Loiselle M, Davis J, Leonard MM, Kuri-Cervantes L, Meyer NJ, Betts MR, Li JZ, Walker BD, Yu XG, Yonker LM, Luban J. Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection. Elife. 2022 03 11; 11.